SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution.
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, with subpopulations of neoplastic cells harboring distinct mutations. A fine resolution view of this clonal architecture provides insight into tumor heterogeneity, evolution, and treatment response, all...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/513fe959e2924b31a6a0830661bda655 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:513fe959e2924b31a6a0830661bda655 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:513fe959e2924b31a6a0830661bda6552021-11-25T05:40:52ZSciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution.1553-734X1553-735810.1371/journal.pcbi.1003665https://doaj.org/article/513fe959e2924b31a6a0830661bda6552014-08-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25102416/?tool=EBIhttps://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, with subpopulations of neoplastic cells harboring distinct mutations. A fine resolution view of this clonal architecture provides insight into tumor heterogeneity, evolution, and treatment response, all of which may have clinical implications. Single tumor analysis already contributes to understanding these phenomena. However, cryptic subclones are frequently revealed by additional patient samples (e.g., collected at relapse or following treatment), indicating that accurately characterizing a tumor requires analyzing multiple samples from the same patient. To address this need, we present SciClone, a computational method that identifies the number and genetic composition of subclones by analyzing the variant allele frequencies of somatic mutations. We use it to detect subclones in acute myeloid leukemia and breast cancer samples that, though present at disease onset, are not evident from a single primary tumor sample. By doing so, we can track tumor evolution and identify the spatial origins of cells resisting therapy.Christopher A MillerBrian S WhiteNathan D DeesMalachi GriffithJohn S WelchObi L GriffithRavi VijMichael H TomassonTimothy A GraubertMatthew J WalterMatthew J EllisWilliam SchierdingJohn F DiPersioTimothy J LeyElaine R MardisRichard K WilsonLi DingPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 10, Iss 8, p e1003665 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Christopher A Miller Brian S White Nathan D Dees Malachi Griffith John S Welch Obi L Griffith Ravi Vij Michael H Tomasson Timothy A Graubert Matthew J Walter Matthew J Ellis William Schierding John F DiPersio Timothy J Ley Elaine R Mardis Richard K Wilson Li Ding SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
description |
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, with subpopulations of neoplastic cells harboring distinct mutations. A fine resolution view of this clonal architecture provides insight into tumor heterogeneity, evolution, and treatment response, all of which may have clinical implications. Single tumor analysis already contributes to understanding these phenomena. However, cryptic subclones are frequently revealed by additional patient samples (e.g., collected at relapse or following treatment), indicating that accurately characterizing a tumor requires analyzing multiple samples from the same patient. To address this need, we present SciClone, a computational method that identifies the number and genetic composition of subclones by analyzing the variant allele frequencies of somatic mutations. We use it to detect subclones in acute myeloid leukemia and breast cancer samples that, though present at disease onset, are not evident from a single primary tumor sample. By doing so, we can track tumor evolution and identify the spatial origins of cells resisting therapy. |
format |
article |
author |
Christopher A Miller Brian S White Nathan D Dees Malachi Griffith John S Welch Obi L Griffith Ravi Vij Michael H Tomasson Timothy A Graubert Matthew J Walter Matthew J Ellis William Schierding John F DiPersio Timothy J Ley Elaine R Mardis Richard K Wilson Li Ding |
author_facet |
Christopher A Miller Brian S White Nathan D Dees Malachi Griffith John S Welch Obi L Griffith Ravi Vij Michael H Tomasson Timothy A Graubert Matthew J Walter Matthew J Ellis William Schierding John F DiPersio Timothy J Ley Elaine R Mardis Richard K Wilson Li Ding |
author_sort |
Christopher A Miller |
title |
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
title_short |
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
title_full |
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
title_fullStr |
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
title_full_unstemmed |
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
title_sort |
sciclone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/513fe959e2924b31a6a0830661bda655 |
work_keys_str_mv |
AT christopheramiller scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT brianswhite scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT nathanddees scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT malachigriffith scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT johnswelch scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT obilgriffith scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT ravivij scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT michaelhtomasson scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT timothyagraubert scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT matthewjwalter scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT matthewjellis scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT williamschierding scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT johnfdipersio scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT timothyjley scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT elainermardis scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT richardkwilson scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution AT liding scicloneinferringclonalarchitectureandtrackingthespatialandtemporalpatternsoftumorevolution |
_version_ |
1718414516660731904 |